NCT07479979 2026-03-18
Study of Selinexor With Carfilzomib, Isatuximab and Dexamethasone for Patients With Relapsed and/or Refractory Multiple Myeloma
Hoosier Cancer Research Network
Phase 1/2 Not yet recruiting
Hoosier Cancer Research Network
Tianjin Medical University Cancer Institute and Hospital
Institute of Hematology & Blood Diseases Hospital, China
University Health Network, Toronto
Institute of Hematology & Blood Diseases Hospital, China
Ruijin Hospital
Ruijin Hospital